tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
Hong Kong Market
9989
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
Overview
News & Insights
Financials
Dividends
Technical Analysis
Chart
Earnings
Ownership
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Income Statement

Compare
0 Followers

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Income Statement

Last quarter (Q3 2024), Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H's total revenue was ¥1.23B, a decrease of -8.80% from the same quarter last year. In Q3, Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H's net income was ¥116.43M. See Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 5.45B¥ 7.16B¥ 6.37B¥ 5.33B¥ 4.62B
Gross Profit
¥ 1.80B¥ 2.33B¥ 2.03B¥ 2.09B¥ 1.73B
Operating Expenses
¥ 2.66B¥ 1.21B¥ 1.07B¥ 960.98M¥ 896.50M
Depreciation and Amortization
¥ 373.60M¥ 307.66M¥ 302.74M¥ 303.99M¥ 255.59M
EBITDA
-¥ 1.37B¥ 726.64M¥ 1.88B¥ 1.83B
Operating Income
¥ -238.11M¥ 1.14B¥ 773.20M¥ 1.33B¥ 1.31B
Other Income/Expenses
-¥ -168.70M¥ -611.27M¥ -2.12M¥ 568.01M
Pretax Income
-¥ 829.85M¥ 222.26M¥ 1.33B¥ 1.31B
Net Income
-¥ 727.43M¥ 240.79M¥ 1.02B¥ 1.06B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ -0.53¥ 0.50¥ 0.16¥ 0.76¥ 0.85
Diluted EPS
¥ -0.53¥ 0.50¥ 0.16¥ 0.76¥ 0.85
Weighted Average Shares Outstanding
 1.47B 1.47B 1.47B 1.35B 1.25B
Weighted Average Shares Outstanding (Diluted)
 1.47B 1.47B 1.47B 1.35B 1.25B
Currency in CNY

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis
Subscribe NowSee Plans & Pricing